SFG
IDXX icon

SNS Financial Group’s Idexx Laboratories IDXX Stock Holding History

SNS Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$681K Buy
+1,293
New +$725K 0.01% 340

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SNS Financial Group's IDXX Position: Q2 2026 in Review

SNS Financial Group opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 1,293 shares worth $681K. The stake represents 0.01% of the portfolio and ranks #340 among its holdings.

1,051 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • SNS Financial Group held 1,293 shares of Idexx Laboratories worth $681K as of Q2 2026.
  • Idexx Laboratories was a new SNS Financial Group position in Q2 2026.
  • Idexx Laboratories made up 0.01% of SNS Financial Group's portfolio in Q2 2026, its #340 holding.
  • 1,051 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.